跳至主要内容
临床试验/NCT01889459
NCT01889459招募中不适用

Patient Registry of Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO) by Japanese Experts

Kurashiki Central Hospital1 个研究点 分布在 1 个国家目标入组 19,000 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
19,000
试验地点
1
主要终点
successful revascularization without any major adverse cardiocerebral events (MACCE) at early follow-up and MACCE during the 5-year follow-up

研究概览

简要总结

The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients eligible for PCI
  • Patients who underwent PCI for CTO lesions that contain the following:
  • Thrombolysis in myocardial infarction trial (TIMI) 0
  • The occlusive period more than 3 months or unknown
  • The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft

排除标准

  • Patients ineligible for PCI judged in clinical practice

结局指标

主要结局

successful revascularization without any major adverse cardiocerebral events (MACCE) at early follow-up and MACCE during the 5-year follow-up

时间窗: within the first 1 month (plus 1 month) after PCI and during the 5-year follow-up

early and late results on major adverse cardiocerebral events (MACCE): all-cause death, coronary artery bypass grafting, re-PCI (target lesion revascularization/target vessel revascularization), admission for heart failure, myocardial infarction, admission for unstable angina, cerebrovascular disease, stent thrombosis in 19000 patients in and outside Japan

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Japanese CTO PCI Expert Registry | 临床试验